Frequency of RAS mutations (KRAS, NRAS, HRAS) in human solid cancer H Kodaz, O Kostek, MB Hacioglu, B Erdogan, CE Kodaz, I Hacibekiroglu, ... Breast cancer 7 (12), 1-7, 2017 | 71 | 2017 |
Incidence of contrast-induced nephropathy in hospitalised patients with cancer I Cicin, B Erdogan, E Gulsen, S Uzunoglu, N Sut, E Turkmen, H Kodaz, ... European radiology 24, 184-190, 2014 | 58 | 2014 |
Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumors H Kodaz, I Hacibekiroglu, B Erdogan, E Turkmen, H Tozkir, D Albayrak, ... Molecular and clinical oncology 3 (1), 179-184, 2015 | 32 | 2015 |
K-RAS and N-RAS mutations in testicular germ cell tumors BM Hacioglu, H Kodaz, B Erdogan, A Cinkaya, E Tastekin, I Hacibekiroglu, ... Bosnian journal of basic medical sciences 17 (2), 159, 2017 | 22 | 2017 |
Clinical features of the patient with multiple primary tumors: Single center experience A Gokyer, O Kostek, MB Hacioglu, B Erdogan, H Kodaz, E Turkmen, ... Northern clinics of Istanbul 4 (1), 43, 2017 | 18 | 2017 |
Comparative analysis of the efficacy and safety of modified FOLFOX-6 and DCF regimens as first-line treatment in advanced gastric cancer I Hacibekiroglu, H Kodaz, B Erdogan, E Turkmen, A Esenkaya, Y Onal, ... Molecular and Clinical Oncology 3 (5), 1160-1164, 2015 | 17 | 2015 |
Single-agent bevacizumab is an effective treatment in recurrent glioblastoma I Hacibekiroglu, H Kodaz, B Erdogan, E Turkmen, M Ozcelik, A Esenkaya, ... Medical Oncology 32, 1-6, 2015 | 14 | 2015 |
Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the A natolian Society of Medical … OU Unal, I Oztop, N Yasar, Z Urakci, T Ozatli, O Bozkurt, A Sevinc, ... Thoracic Cancer 6 (1), 85-90, 2015 | 13 | 2015 |
Efficacy and safety of raltitrexed combinations with uracil-tegafur or mitomycin C as salvage treatment in advanced colorectal cancer patients: a multicenter study of Anatolian … O Bozkurt, H Karaca, A Ciltas, M Kaplan, M Benekli, A Sevinc, U Demirci, ... Asian Pacific Journal of Cancer Prevention 15 (4), 2014 | 13 | 2014 |
Successful treatment strategy of Turkey against Covid-19 Outbreak H Kodaz Eurasian J Med Oncol, 2020 | 12 | 2020 |
KRAS mutation in small cell lung carcinoma and extrapulmonary small cell cancer H Kodaz, E Taştekin, B Erdoğan, İ Hacıbekiroğlu, H Tozkır, H Gürkan, ... Balkan medical journal 33 (4), 407-410, 2016 | 12 | 2016 |
Comparative analysis of the efficacy and safety of oxaliplatin plus 5-fluorouracil/leucovorin (modified FOLFOX6) with advanced gastric cancer patients having a good or poor … I Hacibekiroglu, H Kodaz, B Erdogan, E Turkmen, A Esenkaya, ... Asian Pacific Journal of Cancer Prevention 16 (6), 2355-2359, 2015 | 12 | 2015 |
Unknown primary adenocarcinomas: a single-center experience S Uzunoglu, B Erdogan, H Kodaz, A Cinkaya, E Turkmen, I Hacibekiroglu, ... Bosnian Journal of Basic Medical Sciences 16 (4), 292, 2016 | 9 | 2016 |
Primary Tumor Resection Offers Higher Survival Advantage in KRAS Mutant Metastatic Colorectal Cancer Patients. H Kodaz, B Erdogan, I Hacibekiroglu, E Turkmen, H Tozkir, D Albayrak, ... Hepato-gastroenterology 62 (140), 876-879, 2015 | 9 | 2015 |
Importance of Ki-67 in human epidermal growth factor receptor 2 positive breast cancer B Erdogan, E Turkmen, TD Yalta, U Usta, H Kodaz, İ Hacibekiroglu, ... J BUON 20 (3), 730-736, 2015 | 9 | 2015 |
Synchronous parathyroid carcinoma and multifocal papillary thyroid carcinoma: a case report F Kuzu, A Cinkaya, M Ekici, H Kodaz, A Deger Eurasian Journal of Medicine and Oncology 1 (1), 49-52, 2017 | 8 | 2017 |
The factors that affect the prediction of lymph node metastasis in prostate cancer H Turk, S Ün, O Koca, A Cinkaya, H Kodaz, F Zorlu Journal of Cancer Research and Therapeutics 14 (5), 1094-1098, 2018 | 7 | 2018 |
Metaplastic breast cancer: A case report. S Surenkok, E Tahberer, A Cinkaya, H Kodaz, A Deger JPMA. The Journal of the Pakistan Medical Association 68 (3), 466-468, 2018 | 7 | 2018 |
Post progression survival analysis of metastatic gastric and gastroesophageal junction cancer patients after second-line treatment E Turkmen, B Erdogan, H Kodaz, I Hacibekiroglu, Y Onal, S Uzunoglu, ... Acta Gastro-enterol Belgica 79, 211-5, 2016 | 7 | 2016 |
İleri evre prostat kanserinde hormon tedavisi. İ HACIBEKIROĞLU, H KODAZ, E TÜRKMEN Turkish Journal of Oncology/Türk Onkoloji Dergisi 30 (2), 2015 | 7 | 2015 |